Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Orelabrutinib (ICP-022) | 1655504-04-3 | 100.0% | 100 MG
Supplier: Medchemexpress LLC HY129390100MG
Orelabrutinib is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor with potential antineoplastic activity. It prevents both the activation of the B-cell antigen receptor (BCR) signaling pathway and BTK-mediated activation of downstream survival pathways, thereby inhibiting the growth of malignant B-cells that overexpress BTK.
- Potent, orally active, and irreversible BTK inhibitor
- Prevents B-cell antigen receptor (BCR) signaling pathway activation
- Inhibits BTK-mediated activation of downstream survival pathways
- Inhibits the growth of malignant B-cells that overexpress BTK
- Purity of 99.97%
- Soluble in DMSO at 100 mg/mL
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?